Lowering Barriers to R&D Innovation
We are a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D.
Our projects transform R&D innovation through pre-competitive collaboration. We bring together the key constituents to identify the root causes that lead to R&D inefficiencies. We develop best practices and technology pilots to overcome common obstacles.
Our members collaborate as equals on open projects that generate significant value for the worldwide life sciences community.
With the launch of our Interactive Project Portfolio Platform (IP3) we are embracing a new level of openness, access, and transparency around our idea-to-project process. The platform is open to the public to submit new ideas, comment and vote on proposed ideas, and monitor the progress of our projects.
In those turbulent times, many pharmaceutical companies were still managing some of their R&D information systems on paper. Those that had moved to computer-based systems were tied to the mainframe, with little or no interactive access. All updates and queries were performed in batch mode – apart from online searches of external systems, which were carried out mostly on teletypes.
For those who couldn't make it, the code orientation slides and meeting recording are now available.
* A full list of our membership including individual members can be found here. (Last updated May 18 2018)
- Harvard Users Group Meeting of the i2b2 tranSMART Foundation
27 Jun 2018 - 28 Jun 2018, BOSTON
- Applying NGS Technologies in Precision Medicine
10 Sep 2018, London
- Pistoia Alliance US Conference 2018
10 Oct 2018, Boston